Lifeward overhauls board as Q2 revenue rises 16%, CFO to depart
The neurorehabilitation company added three directors and lost four board members within days of reporting stronger quarterly sales and a planned CFO transition.
Lifeward Ltd. reported second quarter 2026 financial results on August 14, 2026, alongside a wave of board and executive changes. Revenue increased 16% to $6.6 million in the second quarter of 2026 compared to the second quarter of 2025, marking the strongest quarterly revenue performance since the fourth quarter of 2024, which the company attributed to continued execution of its commercial strategy and growing adoption across its rehabilitation portfolio.1 The increase was driven by a 13% rise in ReWalk Personal exoskeleton sales to $2.5 million, reflecting stronger sales in Europe, and a 25% increase in AlterG products and services to $4.1 million, reflecting higher U.S. unit shipments, service revenue and average selling prices.1
Total operating expenses fell 24% to $6.9 million and operating loss declined 37% to $4.2 million, largely due to one-time impairment charges recorded in the prior-year period.1 Net loss was $11.5 million, or $4.12 per share, compared to $6.6 million, or $7.01 per share, a year earlier.1 The company said it strengthened its balance sheet to a proforma cash balance of approximately $11 million, with a $9.4 million cash balance as of June 30, 2026, after raising about $5.6 million through a financing closed on July 6, 2026 that could provide up to $11.2 million in growth capital.1
On the governance side, an August 14 filing disclosed that on August 12, 2026, Robert J. Marshall, Jr., Michael Swinford and William Mark Sigsbee notified the Board of their decision to step down, effective August 13, 20261, and that Almog Adar will step down as Chief Financial Officer, continuing in his role through September 30, 2026 to assist with a transition to a successor1. A subsequent August 20 filing said on August 14, 2026, the Board appointed Yonason Greenwald and Haggai Zamir as Class III Directors2, and on August 20, 2026, appointed Avraham Gabay as a Class III Director who will also serve as Chair of the Board2. The same filing noted on August 20, 2026, Nadav Kidron notified the Board of his decision to step down from the Board, effective immediately2.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.